Health News Highlights: Medical Schools, IPOs, and Drug Developments

This week's health news roundup includes significant strides in the education sector as about 25% of U.S. medical schools commit to enhancing their nutrition curriculum. This effort aligns with a broader governmental agenda, led by Health Secretary Robert F. Kennedy Jr., to prioritize public health initiatives.

Meanwhile, Medtronic's diabetes branch MiniMed has secured $560 million from its U.S. IPO, although commodity and conflict-related market volatility has impacted its Nasdaq debut. Additionally, CVS Health partners with Google Cloud to innovate real-time health management through AI, poised for a 2026 launch.

Other highlights include South Africa's drive to domestically produce an HIV prevention drug and the FDA's approval of a novel Johnson & Johnson blood cancer treatment. The sector also sees regulatory updates, such as Pfizer resolving a securities issue, and discussions on autism research focus shifts with controversial inclusions.